Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Sabine Wächter"'
Autor:
Sabine Wächter, Silvia Roth, Norman Gercke, Ulrike Schötz, Ekkehard Dikomey, Rita Engenhart-Cabillic, Elisabeth Maurer, Detlef K. Bartsch, Pietro Di Fazio
Publikováno v:
Life, Vol 13, Iss 6, p 1397 (2023)
Radiotherapy and immunotherapy have shown promising efficacy for the treatment of solid malignancies. Here, we aim to clarify the potential of a combined application of radiotherapy and programmed cell death-ligand 1 (PD-L1) monoclonal antibody atezo
Externí odkaz:
https://doaj.org/article/3ee6f125295c4a42903afedbaeba15c5
Autor:
Petros Stathopoulos, Malte Zumblick, Sabine Wächter, Leif Schiffmann, Thomas M. Gress, Detlef Bartsch, Guido Seitz, Ulrike W. Denzer
Publikováno v:
Endoscopy International Open, Vol 10, Iss 05, Pp E686-E693 (2022)
Background and study aims Acute esophageal perforation is a potentially life-threating condition that demands a multidisciplinary approach. Based on recently published data indicating that EVT may be effective in managing esophageal perforation, we r
Externí odkaz:
https://doaj.org/article/218e18fbec384bf3b7ff36bbe6a5af42
Publikováno v:
Journal of Digestive Endoscopy, Vol 11, Iss 04, Pp 287-289 (2020)
Pemphigus vulgaris (PV) is a rare autoimmune disease affecting the skin and mucous membranes. Recent studies have shown a relatively high incidence of esophageal involvement in PV. To distinguish between the esophageal involvement of PV and other pat
Externí odkaz:
https://doaj.org/article/d6cd1a0a52bf4bbc933605696630e9c4
Autor:
Sabine Wächter, Pietro Di Fazio, Elisabeth Maurer, Jerena Manoharan, Corinna Keber, Andreas Pfestroff, Damiano Librizzi, Detlef K. Bartsch, Markus Luster, Friederike Eilsberger
Publikováno v:
Cancers, Vol 13, Iss 22, p 5688 (2021)
Several studies have demonstrated an expression of the prostate-specific membrane antigen (PSMA) in the cancer-related neovasculature of thyroid malignancies. Due to the poor prognosis and limited therapeutic options for patients with anaplastic (ATC
Externí odkaz:
https://doaj.org/article/9e1c2bdd96834eab9765d9c931a04e75
Autor:
Sabine Wächter, Annette Wunderlich, Brandon H. Greene, Silvia Roth, Moritz Elxnat, Sebastian A. Fellinger, Frederik A. Verburg, Markus Luster, Detlef K. Bartsch, Pietro Di Fazio
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 7, p 2077 (2018)
Background: The MEK (mitogen-activated protein kinase)–inhibitor selumetinib led to increased radioiodine uptake and retention in a subgroup of patients suffering from radioiodine refractory differentiated thyroid cancer (RR-DTC). We aimed to analy
Externí odkaz:
https://doaj.org/article/aaa78e7334f744e6b11c193ff96d9986
Autor:
Sabine Wächter, Annette Wunderlich, Silvia Roth, Ioannis Mintziras, Elisabeth Maurer, Sebastian Hoffmann, Frederik A. Verburg, Sebastian A. Fellinger, Katharina Holzer, Detlef K. Bartsch, Pietro Di Fazio
Publikováno v:
Journal of Clinical Medicine, Vol 7, Iss 5, p 115 (2018)
The prognosis of anaplastic (ATC) and poorly differentiated thyroid cancer (PDTC) is poor, due to their radioiodine refractoriness (RAI-R), high metastatic potential and current lack of effective treatment strategies. We aimed to examine the efficacy
Externí odkaz:
https://doaj.org/article/6e1d8a7a3b614b828d688f0e6a7a7ba8
Autor:
Sabine Wächter, Alexander I. Damanakis, Moritz Elxnat, Silvia Roth, Annette Wunderlich, Frederik A. Verburg, Sebastian A. Fellinger, Detlef K. Bartsch, Pietro Di Fazio
Publikováno v:
Journal of Clinical Medicine, Vol 7, Iss 4, p 61 (2018)
Epigenetic modifications have been identified as being responsible for the de-differentiation of thyroid tissue and its malignant transformation. Cell proliferation inhibitory effects of the pan-deacetylase inhibitors panobinostat, SAHA and Trichosta
Externí odkaz:
https://doaj.org/article/f693ca15514e4dad9a9b5268307362f9
Autor:
Sabine Wächter, Franziska Knauff, Silvia Roth, Corinna Keber, Katharina Holzer, Jerena Manoharan, Elisabeth Maurer, Detlef K. Bartsch, Pietro Di Fazio
Publikováno v:
Cancer Investigation. 41:405-421
Anaplastic thyroid carcinoma (ATC) has poor prognosis, high mortality rate and lack of effective therapy. A synergic combination of PD-L1 antibody together with cell death promoting substances like deacetylase inhibitors (DACi) and multi-kinase inhib
Autor:
Fazio, Sabine Wächter, Silvia Roth, Norman Gercke, Ulrike Schötz, Ekkehard Dikomey, Rita Engenhart-Cabillic, Elisabeth Maurer, Detlef K. Bartsch, Pietro Di
Publikováno v:
Life; Volume 13; Issue 6; Pages: 1397
Radiotherapy and immunotherapy have shown promising efficacy for the treatment of solid malignancies. Here, we aim to clarify the potential of a combined application of radiotherapy and programmed cell death-ligand 1 (PD-L1) monoclonal antibody atezo
Autor:
Sabine Wächter, Katharina Holzer
Publikováno v:
Die Chirurgie.